ConductScience.org, home

Paper32047366

Personalized Pharmacotherapy for Bipolar Disorder: How to Tailor Findings From Randomized Trials to Individual Patient-Level Outcomes.

Goldberg JF. Focus (Am Psychiatr Publ), 2019. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. Personalized Pharmacotherapy for Bipolar Disorder: How to Tailor Findings From Randomized Trials to Individual Patient-Level Outcomes. Papers, record 32047366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32047366

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Personalized Pharmacotherapy for Bipolar Disorder: How to Tailor Findings From Randomized Trials to Individual Patient-Level Outcomes.
PubMed
Journal
Focus (Am Psychiatr Publ)
PubMed
Year
2019
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
0.45
iCite
Revised in PubMed
2024-03-28
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Goldberg JFJoseph F

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References128

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
119200421Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial.J Clin Psychiatry2009https://conductscience.org/library/papers/19200421PubMed
228969438Adjunctive Bright Light Therapy for Bipolar Depression: A Randomized Double-Blind Placebo-Controlled Trial.Am J Psychiatry2018https://conductscience.org/library/papers/28969438PubMed
316259532Prevalence, correlates, and comorbidity of bipolar I disorder and axis I and II disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.J Clin Psychiatry2005https://conductscience.org/library/papers/16259532PubMed
419624385The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders.Bipolar Disord2009https://conductscience.org/library/papers/19624385PubMed
525280430Bipolar I and II versus unipolar depression: clinical differences and impulsivity/aggression traits.Eur Psychiatry2015https://conductscience.org/library/papers/25280430PubMed
620015083Is anticonvulsant treatment of mania a class effect? Data from randomized clinical trials.CNS Neurosci Ther2011https://conductscience.org/library/papers/20015083PubMed
724170180Lurasidone monotherapy in the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study.Am J Psychiatry2014https://conductscience.org/library/papers/24170180PubMed
823107222Lamotrigine as add-on treatment to lithium and divalproex: lessons learned from a double-blind, placebo-controlled trial in rapid-cycling bipolar disorder.Bipolar Disord2012https://conductscience.org/library/papers/23107222PubMed
928146613Efficacy and Safety of Aripiprazole Once-Monthly in the Maintenance Treatment of Bipolar I Disorder: A Double-Blind, Placebo-Controlled, 52-Week Randomized Withdrawal Study.J Clin Psychiatry2017https://conductscience.org/library/papers/28146613PubMed
1032047367Complex Combination Pharmacotherapy for Bipolar Disorder: Knowing When Less Is More or More Is Better.Focus (Am Psychiatr Publ)2019https://conductscience.org/library/papers/32047367PubMed
1118052562Gabapentin reduces alcohol consumption and craving: a randomized, double-blind, placebo-controlled trial.J Clin Psychiatry2007https://conductscience.org/library/papers/18052562PubMed
1212680900Phenotypic spectra of bipolar disorder in responders to lithium versus lamotrigine.Bipolar Disord2003https://conductscience.org/library/papers/12680900PubMed
1325647451A pilot randomized placebo-controlled trial of adjunctive aripiprazole for chronic PTSD in US military Veterans resistant to antidepressant treatment.Int Clin Psychopharmacol2015https://conductscience.org/library/papers/25647451PubMed
1420092882Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial.Lancet2010https://conductscience.org/library/papers/20092882PubMed
1523288387Lithium treatment moderate-dose use study (LiTMUS) for bipolar disorder: a randomized comparative effectiveness trial of optimized personalized treatment with and without lithium.Am J Psychiatry2013https://conductscience.org/library/papers/23288387PubMed
1617604407Negative effects of antiepileptic drugs on mood in patients with epilepsy.Drug Saf2007https://conductscience.org/library/papers/17604407PubMed
1724627538Zonisamide reduces obstructive sleep apnoea: a randomised placebo-controlled study.Eur Respir J2014https://conductscience.org/library/papers/24627538PubMed
1824170221Lurasidone as adjunctive therapy with lithium or valproate for the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study.Am J Psychiatry2014https://conductscience.org/library/papers/24170221PubMed
1912767733Oral topiramate for treatment of alcohol dependence: a randomised controlled trial.Lancet2003https://conductscience.org/library/papers/12767733PubMed
2026233320The prevalence and predictors of comorbid bipolar disorder and obsessive-compulsive disorder: A systematic review and meta-analysis.J Affect Disord2015https://conductscience.org/library/papers/26233320PubMed

See all 128 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
42964582Inpatient Lurasidone Treatment for Adolescent Bipolar Depression: A Retrospective Study.Psychiatry Clin Psychopharmacol2026https://conductscience.org/library/papers/42964582PubMed
40426603Perspectives on Precision Psychiatry Using Antipsychotics in the Management of Bipolar Disorder.Brain Sci2025https://conductscience.org/library/papers/40426603PubMed
40355996Antidepressants in Bipolar Depression: From Neurotransmitter Mechanisms to Clinical Challenges.Actas Esp Psiquiatr2025https://conductscience.org/library/papers/40355996PubMed
39061448The Advantages of Combining Therapies in Treating Psychiatric Patients.Brain Sci2024https://conductscience.org/library/papers/39061448PubMed
33796268Hamlet's augury: how to manage discontinuation of mood stabilizers in bipolar disorder.Ther Adv Psychopharmacol2021https://conductscience.org/library/papers/33796268PubMed
32047367Complex Combination Pharmacotherapy for Bipolar Disorder: Knowing When Less Is More or More Is Better.Focus (Am Psychiatr Publ)2019https://conductscience.org/library/papers/32047367PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32047366

GET https://conductscience.org/api/papers/v1/32047366/references?page=2